Health
Johnson & Johnson Launches 'Gut Tunnel' Experience in Singapore to Highlight the Importance of Endoscopic Remission in IBD
Ahead of World IBD Day, Johnson & Johnson today launched the interactive 'Gut Tunnel' experience in Singapore, alongside educational programs across Asia Pacific, to empower people living with inflammatory bowel disease (IBD) to pursue endoscopic remission, a critical yet under-recognized treatment goal, as part of its ongoing Dual Control campaign.
About this update from Johnson & Johnson
[{"type":"text","content":"New data presented at Digestive Disease Week 2026 reinforces endoscopic remission as being associated with long-term patient outcomes,[1],[2] yet more than 60% of people with IBD have not heard of this key treatment goal.[3],[4]","length":228,"tagName":"p"},{"type":"text","content":"Anchoring World IBD Day, the interactive Gut Tunnel installation (18–21 May, Asia Square 2, Singapore) makes invisible inflammation and deeper gut-level control easier to understand.","length":182,"tagName":"p"},{"type":"text","content":"SINGAPORE, May 18, 2026 /PRNewswire/ -- Ahead of World IBD Day, Johnson & Johnson today launched the interactive 'Gut Tunnel' experience in Singapore, alongside educational programs across Asia Pacific, to empower people living with inflammatory bowel disease (IBD) to pursue endoscopic remission, a critical yet under-recognized treatment goal, as part of its ongoing Dual Control campaign.","length":403,"tagName":"p"},{"type":"text","content":"New data presented at Digestive Disease Week 2026 reinforces that endoscopic remission, defined as the absence of disease activity observed during a colonoscopy,[3] is associated with improved long-term patient outcomes.","length":225,"tagName":"p"},{"type":"text","content":"Ulacerative colitis (UC) patients achieving endoscopic remission had a 68% lower risk of symptom worsening and were 4 times less likely to require IBD-related surgery. [2] Crohn's disease (CD) patients who achieved endoscopic remission showed a 41% lower risk of symptom worsening, were 3 times less likely to require IBD-related surgery and had reduced steroid use.[1] However, more than 60% of people with IBD have not heard of this key treatment goal,[2,3] highlighting a significant knowledge gap among patients.","length":535,"tagName":"p"},{"type":"text","content":""Decades of innovation have advanced IBD care. Endoscopic remission is now the long-term treatment goal for IBD, and it indicates deeper healing and drives better patient outcomes," said Sung-Ae Jung, MD, PhD, President of the Korean Association for the Study of Intestinal Diseases, Korea.","length":330,"tagName":"p"},{"type":"image","alt":"Control Inside, Control Your Dreams. Discuss IBD remission with your doctor. Live fully.","displaySize":"","headline":null,"caption":"...